e-learning
resources
Virtual 2021
07.09.2021
Better understanding of sarcoidosis: new keys
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
FeV1 and body weight weight on LCQ in sarcoidosis patients
B. Frye (Freiburg, Germany), D. Soriano (Freiburg, Germany), E. Farin (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America)
Source:
Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Session:
Better understanding of sarcoidosis: new keys
Session type:
Oral Presentation
Number:
3983
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Frye (Freiburg, Germany), D. Soriano (Freiburg, Germany), E. Farin (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America). FeV1 and body weight weight on LCQ in sarcoidosis patients. 3983
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Association of weight loss in COPD patients with low body mass index on outcomes
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011
Low fat-free mass and body mass index are associated with worse survival in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Body fat mass in patients with COPD after stratification for BMI and FFMI
Source: Eur Respir J 2007; 30: Suppl. 51, 453s
Year: 2007
Relationship between body mass index (BMI) and decline in FVC in patients with IPF
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Body mass index as predictor for asthma: a cohort study of 118,723 males and females
Source: Eur Respir J 2010; 35: 1235-1242
Year: 2010
Influence of body weight and fat mass on pulmonary function and performance status of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003
Does incresaed body mass index effect the gain of pulmonary rehabilitation on COPD patients?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Body mass index and asthma severity in children
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Body mass index, weight gain and activity-related breathlessness: the Swedish CArdioPulmonary bioImage Study
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019
Relationships between pulmonary function tests and body mass index and body composition in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005
Body mass index and asthma severity
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008
Impact of dyspnoea scores, body mass index and fat free mass on distribution of disease severity
Source: Eur Respir J 2004; 24: Suppl. 48, 689s
Year: 2004
Body mass index and quality of life in patients with asthma
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Impact of the body mass index on the FEV
1
value and its mean yearly decline in COPD patients
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Influence of the body mass index on the survival of COPD patients
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Association between body mass index and asthma symptoms
Source: Annual Congress 2008 - Asthma epidemiology
Year: 2008
Dyspnea and mortality in elderly: the role of the body mass index (BMI)
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Relation between body mass index and spirometry in obese children
Source: Eur Respir J 2005; 26: Suppl. 49, 676s
Year: 2005
The relationship between body mass index and asthma control
Source: Eur Respir J 2006; 28: Suppl. 50, 322s
Year: 2006
Relation of asthma and body mass index in children
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept